This report highlights selected evidence of different cancer patterns among African Americans and whites and considers potential risk factors associated with these cancers. During the years 1987 to 1991, African Americans experienced higher incidence and mortality rates than whites for multiple myeloma and for cancers of the oropharynx, colorectum, lung and bronchus, cervix, and prostate. African Americans had lower incidence and mortality for cancer of the urinary bladder. The incidence of breast cancer was higher among white women, but mortality was higher among African American women. Five-year relative survival for the period 1983 to 1990 was generally lower among African Americans than whites for cancers of the oropharynx, colorectum, cervix, prostate, and female breast but slightly higher for multiple myeloma. From 1973 to 1991, there were significant declines in cervical cancer incidence among women of both races, oropharyngeal cancer mortality among whites, and bladder cancer mortality for whites and African Americans. Risk factors for the more prominent cancers suggest that efforts aimed at changing lifestyles, achieving socioeconomic parity, and insuring environmental equity are likely to relieve African Americans of much of their disproportionate cancer burden. -Environ Health Perspect 103(Suppl 8): 275-281 (1995) 
Introduction
Interest has intensified in recent years regarding the variation of cancer incidence and mortality among racial groups, particularly among African Americans, who comprise the largest racial minority group in the United States (1) . Particularly germane are demographic changes, the lack of substantial gains against established cancers, and increasing evidence that higher percentages of African Americans and Hispanics than whites live in areas polluted by potential environmental carcinogens (2) . Descriptive and analytic epidemiologic studies have provided abundant information concerning the African American community's disproportionate cancer burden, a burden that is marked by increasing mortality rates for many cancers in sharp contrast to more favorable trends among whites (3) .
During the period from 1987 to 1991, African Americans in the United States experienced higher incidence and mortality rates than whites for multiple myeloma and for cancers of the oropharynx, colorectum, lung and bronchus, cervix, and prostate, (Table 1 ). African Americans had lower incidence and mortality for cancer of the urinary bladder. The incidence of breast cancer was higher among white women, but mortality was higher among African American women. Five-year relative survival for the period 1983 to 1990 generally was lower among African Americans than whites for cancers of the oropharynx, colorectum, cervix, prostate, and female breast, but slightly higher for multiple myeloma. From 1973 to 1991, there were significant declines in cervical cancer incidence among women of both races, oropharyngeal cancer mortality among whites, and bladder cancer mortality among both whites and African Americans. This report highlights selected cancer sites and briefly considers some of the potential risk factors investigated to explain differences in incidence and mortality among African Americans and whites. More detailed discussions of risk factors such as socioeconomic status (4) (5) (6) (7) (8) (9) (10) (11) can be found elsewhere.
Oral Cavity and Pharynx
The National Cancer Institute estimated that there would be 29,600 new cases and 7925 deaths in 1994 attributable to cancer of the oral cavity and pharynx, including lip, salivary gland, and nasopharynx (Table  1 ) (3). African American men have the highest incidence and mortality rates, and the racial disparity has been increasing over time. African American men are the only racial/gender group to experience increases in both incidence and mortality during the 1987 to 1991 period (3). In addition, African American men have the poorest 5-year survival rates for these types ofcancer.
The primary risk factors for cancer of the oral cavity and pharynx are alcohol and tobacco consumption (12) . Day et al. (12) 1987-1991, 1973-1991, 1987-1991, 1973-1991, 1983-1990, 1994 (18) (19) (20) . Research regarding the role of these genetic differences in lung cancer etiology is under way. Socioeconomic factors may also explain some of the racial variation in lung cancer (21) . Differential environmental and occupational exposures may also may explain a portion of the lung cancer excess. There is some evidence that African Americans disproportionately reside or work in areas exposed to industrial chemicals (2, 22 (33, 35) , health care access (35) (36) (37) , age (38) , proximity or contact with pesticides (39), diet (40) , and genetic susceptibility (41, 42) .
One of the earliest analysis of factors associated with stage at diagnosis for breast cancer among African American and white women was conducted by the National Cancer Institute's African American/White Cancer Survival Study Group (43) . It assessed in a single study the The 5-year survival differences among women with the same stage disease suggest that the clinical course of the disease is different among African American women (45) . As with other cancers, age modifies risk, and African American mortality rates decline below those found among whites above age 69 (3).
Uterine Cervix
Cancer of the uterine cervix is the third most common malignancy of the female reproductive system in the United States (3). The incidence among African American women is approximately twice that found among white women-14.0 per 100,000 women compared to 7.8 per 100,000 women, respectively (3). This disparity is evident primarily among women age 65 and over, with African American women experiencing nearly 3 times the incidence of white women during the years 1987 to 1991 (41.8 per 100,000 women compared to 15.3 per 100,000 women) (3) . African American mortality rates (6.7 per 100,000) have been about 3 times that among whites (2.6 per 100,000), which is also primarily attributed to the excess incidence of cervix cancer among African American women age 65 and over (3) . Between 1973 and 1991, the incidence of invasive cervical cancer decreased for both African Americans and whites by 55 Although the incidence and mortality rates associated with prostate cancer are higher among African Americans than whites in the United States, there are wide variations in the incidence of prostate cancer among African populations (47) . In Nigeria and the Caribbean, prostate cancer incidence is much lower than among African Americans. This suggests that migration and accompanying changes in environmental conditions may have affected prostate cancer risk among African Americans (48) .
Prostate cancer is biologically heterogenous in presentation and outcome. It remains latent in some men but intensively aggressive in others. The proportion of early curable prostate cancer has increased (49) . In 1990, African American men were more likely to be diagnosed with stage IV (29.3%) prostate cancer than white men (17.8%). African American men had poorer 5-year survival (66.4%) than white men (81.3%) (3) . This corresponded to a greater prevalence of advanced prostate cancer among African American men. Whether this difference could be explained by differences in urinary obstructive symptoms was investigated by Brawn et al. (50) . They concluded that survival, stratified by stage and grade, was not affected adversely by obstructive symptoms. Neither racial differences in the incidence of obstructive symptoms nor the frequency with which obstructive symptoms required surgical correction explain the later stage at diagnosis found among African American men. Presentation at a later stage was almost twice as common among rural African Americans as among urban African Americans, suggesting a possible role for socioeconomic factors and access to health care (51) .
The etiology of prostate cancer has not been well characterized and many unresolved issues remain. Some investigations have indicated that individuals with prostate cancer tend to consume more dietary animal fat than those not diagnosed and, therefore, a vegetarian lifestyle may reduce risk (48) . Prostate cancer has also been linked to a history of venereal disease, having multiple sexual partners, and some occupations, primarily farming and jobs involving exposure to cadmium (48) . In one study of prostate cancer in the southeastern United States, farming accounted for 38% of the geographic difference in prostate cancer mortality rates among African Americans (52) . Detailed studies of specific agricultural exposures and prostate cancer among African American men have not been conducted to date. Vasectomy has been identified as a potential risk factor for prostate cancer in some studies but not in others (53) . In any event, vasectomy cannot explain the excess risk among African Americans, because the prevalence of vasectomy is much lower among African Americans than whites (53) . Tobacco use does not appear to be associated with prostate cancer nor does it explain the racial disparities (54) .
A rapidly evolving interest in familiar aggregation of prostate cancer has expanded the base of evidence supporting family history as a risk factor for this disease. A hospital-based study found a 2-fold elevated risk among men who had a father or brother with carcinoma of the prostate (55 diagnosed with this type of cancer than among whites (Tables 3,4). The higher incidence among whites is primarily due to excess localized tumors, whereas the incidence of more advanced tumors is similar among both racial groups (60) . These data suggest that whites are more likely to be diagnosed with conditions that go undetected among African Americans and are less likely to progress to more extensive disease. Among both African Americans and whites in one large case-control study, smoking accounted for most of the bladder cancer risk (48 and 43%, respectively) (60 
Conclusion
Available data suggest that there continue to be differences by race in the incidence and mortality for common types of cancers. Studies of these patterns suggest etiologic factors and have led to the identification of probable causes. These factors, however, generally fail to satisfactorily explain the racial differences in incidence and mortality rates. This may be due to the inappropriate use of race and ethnicity as surrogates for social and economic status. It may be easier to use race as a surrogate for social and economic status than to identify a person of color who has limited resources, lives in a substandard residential environment, works in a high-risk occupational setting, or is a single parent exposed to multiple risk factors-psychological, physiological, or both. Focusing on the poor surrogate of race, however, may limit the sensitivity of our research.
There are racial biologic variations and within-race individual differences, both inherited and acquired. These differences may modify various phases of the multistage process of carcinogenesis such as the capacity to convert procarcinogens to carcinogens, to detoxify carcinogens, and to repair DNA. Future progress in untangling the multifactorial dimensions of African American/white differences in cancer burden must move beyond traditional epidemiologic methods. Cancer risk characterization must include more emphasis on biological evaluation of qualitative interindividual differences in susceptibility. This approach can be enhanced by significant advances that have been achieved in the molecular, genetic, and biologic aspects of the more common types of cancers.
The intense activity of those studying the molecular and genetic aspect of human cancer undoubtedly will generate further advances in the identification and characterization of cancer risk. Thus, it does not seem overly optimistic to suggest that approaches that combine clinical, epidemiological, and molecular research ultimately will illuminate more clearly the primary and secondary determinants of racial/ethnic differences in cancer incidence and mortality. The results of this research in conjunction with lifestyle changes, socioeconomic parity, and environmental equity, has the potential to bring about the most effective prevention and control strategies to relieve African Americans of their disproportionate share of the cancer burden.
